** Gene sequencing equipment maker Illumina's ILMN.O shares fall 2.62% to $82 premarket
** China bans ILMN's gene sequencers, just minutes after U.S. President Donald Trump's additional 10% tariff took effect
** Beijing had put Illumina on its "unreliable entity" list in February
** Sales in China account for about 7% of the company's revenue
** Stock has fallen 37% in the past 12 months
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.